Form EFFECT Minerva Neurosciences,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 19, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gorvulikent Unveils Its Next-Generation AI Trading Platform, Redefining Intelligent Investing in 2026
- Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
- XPENG Unveils X-Mind: Empowering Autonomous Driving with a "Future-Foresight" Brain
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share